arrow
返回

Artificial intelligence-driven computational methods for antibody design and optimization

delete2025-07-18
delete0
delete
OA
AI
L
Luiz Felipe Vecchietti
B
Bryan Nathanael Wijaya
A
Azamat Armanuly
B
Begench Hangeldiyev
H
Hyunkyu Jung
S
Sooyeon Lee
M
Meeyoung Cha *
H
Ho Min Kim *
DOI:10.1080/19420862.2025.2528902delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Antibodies play a crucial role in our immune system. Their ability to bind to and neutralize pathogens opens opportunities to develop antibodies for therapeutic and diagnostic use. Computational methods capable of designing antibodies for a target antigen can revolutionize drug discovery, reducing the time and cost required for drug development. Artificial intelligence (AI) methods have recently achieved remarkable advancements in the design of protein sequences and structures, including the ability to generate scaffolds for a given motif and binders for a specific target. These generative methods have been applied to antigen-conditioned antibody design, with experimental binding confirmed for de novo-designed antibodies. This review surveys current AI methods used in antibody development, focusing on those for antigen-conditioned antibody design. The results obtained by AI-based methodologies in antibody and protein research suggest a promising direction for generating de novo binders for various target antigens.
Keyword:
Antibody design
generative artificial intelligence
machine learning
protein design
structural biology
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

mAbs 封面图
mAbs
IF:
7.3
论文数:
1.8K
被引数:
7.2K

机构

U
universitätsstraße 140
学者数:
2
论文数: 1
被引数: 0
引用论文

引用论文

学者 查看更多内容